Showing results (341-350 of 1,640) with videos related to

Sort By:
Pageof 164
Blood|July 27, 2000
Selection and characterization of BCR-ABL positive cell lines with differential sensitivity to the tyrosine kinase inhibitor STI571: diverse mechanisms of resistanceF X Mahon, M W Deininger, B Schultheis, et al.
Leukemia & Lymphoma|January 29, 2011
Oral idarubicin and low dose cytarabine as the initial treatment of acute myeloid leukemia in elderly patientsJ L Harousseau, F Huguet, J Reiffers, et al.
Leukemia & Lymphoma|June 1, 1997
Improving the cytogenetic response to interferon alpha by zidovudine (AZT) in an HIV-positive chronic myelogenous leukemia patientF X Mahon, C B Nabera, J L Pellegrin, et al.
Leukemia|October 1, 1989
Acute nonlymphocytic leukemia with marrow eosinophilia and chromosome 16 abnormality: a report of 18 casesP Bernard, D Dachary, J Reiffers, et al.
Leukemia Research|February 1, 1997
Study of the apoptosis induced in vitro by antitumoral drugs on leukaemic cellsJ P Vial, F Belloc, P Dumain, et al.
Leukemia|June 1, 1992
Complete cytogenetic conversion in chronic myelocytic leukemia patients undergoing interferon alpha therapy: follow-up with reverse polymerase chain reactionC Bilhou-Nabera, F Viard, G Marit, et al.
Leukemia|January 19, 2000
Expression of Flt3-ligand by the endothelial cellA Solanilla, C Grosset, C Lemercier, et al.
American Journal of Clinical Pathology|November 1, 1995
Evaluation of the leukocyte differential flags on an hematologic analyzer. The Cobas Argos 5 DiffF Lacombe, N Cazaux, A Briais, et al.
Leukemia|December 1, 1995
Chronic myelocytic leukemia patients achieving complete cytogenetic conversion under interferon alpha therapy: minimal residual disease follow-upC Bilhou-Nabéra, G Marit, M J Gharbi, et al.
Blood|May 23, 2001
Expression of interferon-alpha (IFN-alpha) receptor 2c at diagnosis is associated with cytogenetic response in IFN-alpha-treated chronic myeloid leukemiaC Barthe, F X Mahon, M J Gharbi, et al.
Pageof 164